Uji Aktivitas Antikoagulan Ekstrak Daun Ciplukan (Physalis Angulata L) Secara Invitro
Anticoagulant Activity Test of Ciplukan Leaf Extract (Physalis Angulata L) Invitro
DOI:
https://doi.org/10.25026/mpc.v14i1.590Keywords:
anticoagulant, Physalis angulata L, secondary metabolitesAbstract
Ciplukan leaf (Physalis angulata L) is empirically used as a hypercoagulation drug. The content of flavonoid secondary metabolites has potential as an anticoagulant. This study aims to determine the yield of ciplukan leaf extract and fraction, the content of secondary metabolites, and its activity as an anticoagulant. The method used in testing anticoagulant activity is Lee White and blood smear. Ciplukan leaves was extracted by maceration method using 70% ethanol solvent. The test samples for the extract and fraction of ciplukan leaves were made in 3 variations of concentration, that is 0.1%; 0.5%; and 1%. The results of ciplukan leaf extract, n hexane fraction, ethyl acetate and distilled water fraction were 14.284%; 12.9%; 10%; and 19.5%. The results of the phytochemical screening test of 70% ethanol extract contain secondary metabolites of flavonoids, alkaloids, tannins, phenols, saponins, steroids, triterpenoids. n?hexane fraction contains alkaloids, steroids and triterpenoids. The ethyl acetate fraction contains flavonoids, phenols and tannins. While the distilled water fraction contains flavonoids, phenols, tannins and saponins. Based on the test results of the Lee White method, extracts and fractions of ciplukan leaves have anticoagulant activity where blood clots do not occur after 2 hours of observation. In the blood smear method, the blood cells are round and not clustered. The best test sample concentration is at a concentration of 1%. The anticoagulant activity of the positive control was better than that of the ciplukan leaf extract and fraction.
References
Abdi Z, Dhanu R, Handayani S, et al. Perbandingan Status Koagulasi Penderita Stroke Iskemik Dengan Non Stroke. Maj Kedokt Nusant J Med Sch. 2012;45(2):96-99.
Gross PL, Weitz JI. New antithrombotic drugs. Clin Pharmacol Ther. 2009;86(2):139-146. doi:10.1038/clpt.2009.98
Krisnayanti MW. Penggunaan Antikoagulan Oral Baru Pada Fibrilasi Atrium. J Farm Udayana. 2019;8(1):1. doi:10.24843/jfu.2019.v08.i01.p01
ROHYANI IS. Kandungan fitokimia beberapa jenis tumbuhan lokal yang sering dimanfaatkan sebagai bahan baku obat. Pros Semin Nas Masy Biodiversitas Indones. 2015;1:388-391. doi:10.13057/psnmbi/m010237
Choi JH, Kim KJ, Kim S. Comparative Effect of Quercetin and Quercetin-3-O-?-d-Glucoside on Fibrin Polymers, Blood Clots, and in Rodent Models. J Biochem Mol Toxicol. 2016;30(11):548-558. doi:10.1002/jbt.21822
Pratiwi L, Fudholi A, Martien R, Pramono S. Ethanol Extract, Ethyl Acetate Extract, Ethyl Acetate Fraction, and n-Heksan Fraction Mangosteen Peels (Garcinia mangostana L.) As Source of Bioactive Substance Free-Radical Scavengers. JPSCR J Pharm Sci Clin Res. 2016;1(2):71. doi:10.20961/jpscr.v1i2.1936
Selawa W, Revolta M, Runtuwene J, et al. KANDUNGAN FLAVONOID DAN KAPASITAS ANTIOKSIDAN TOTAL EKSTRAK ETANOL DAUN BINAHONG [Anredera cordifolia(Ten.)Steenis.]. Pharmacon. 2013;2(1):18-23. doi:10.35799/pha.2.2013.1018
Dewatisari WF, Rumiyanti L, Rakhmawati I. Rendemen dan Skrining Fitokimia pada Ekstrak Daun Sanseviera sp. J Penelit Pertan Terap. 2018;17(3):197. doi:10.25181/jppt.v17i3.336
Padmasari PD, Astuti KW, Warditiani NK. Skrining Fitokimia Ekstrak Etanol 70% Rimpang Bangle (Zingiber purpureum Roxb.). Journal. 2013;366:1-7.
Ku SK, Lee IC, Kim JA, Bae JS. Antithrombotic activities of pellitorine in vitro and in vivo. Fitoterapia. 2013;91:1-8. doi:10.1016/j.fitote.2013.08.004
Armiyanti L, Paransa DS, Gerung GS. Uji Aktivitas Antikoagulan Pada Sel Darah Manusia dari Ekstrak Alga Coklat Turbinaria ornata. J Pesisir Dan Laut Trop. 2013;1(2):21. doi:10.35800/jplt.1.2.2013.2094
Tangkery RAB, Paransa DS, Rumengan A. UJI AKTIVITAS ANTIKOAGULAN EKSTRAK MANGROVE Aegiceras corniculatum. J Pesisir Dan Laut Trop. 2013;1(1):7. doi:10.35800/jplt.1.1.2013.1278
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Proceeding of Mulawarman Pharmaceuticals Conferences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.